Skip to main content
Rabindra Watson, MD, Gastroenterology, Los Angeles, CA

Rabindra Richard Watson MD FASGE

Advanced Endoscopic Interventional, Biliary Tract Disease, Pancreas Disease, Bariatric Medicine


Associate Clinical Professor of Medicine, Cedars-Sinai, Geffen School of Medicine at UCLA

Join to View Full Profile
  • 8700 Beverly Blvdsuite 7700Los Angeles, CA 90048

  • Phone+1 310-423-6082

  • Fax+1 310-423-1826

Dr. Watson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • http://www.npr.org/blogs/health/2015/01/19/377731653/when-bariatric-surgerys-benefits-wane-this-procedure-can-help

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalFellowship, Gastroenterology, 2010 - 2011
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalFellowship, Gastroenterology, 2010 - 2011
  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Gastroenterology, 2007 - 2010
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 2004 - 2007
  • University of California, Davis, School of Medicine
    University of California, Davis, School of MedicineClass of 2004

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2006 - 2026
  • Obesity Medicine
    American Board of Obesity Medicine Obesity Medicine

Publications & Presentations

PubMed

Authored Content

  • Inspection of Endoscope Instrument Channels After Reprocessing Using a Prototype BorescopeMay 2018

Press Mentions

  • New Cedars-Sinai Study Investigates Shifting Trends in GLP-1RA Prescription
    New Cedars-Sinai Study Investigates Shifting Trends in GLP-1RA PrescriptionJuly 22nd, 2024
  • The Utility of EUS-FNA to Determine Surgical Candidacy in Patients with Pancreatic Cancer After Neoadjuvant Therapy
    The Utility of EUS-FNA to Determine Surgical Candidacy in Patients with Pancreatic Cancer After Neoadjuvant TherapyDecember 10th, 2019
  • Obesity Issues - Rabindra R. Watson, MD | UCLA Digestive Diseases
    Obesity Issues - Rabindra R. Watson, MD | UCLA Digestive DiseasesOctober 10th, 2016

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: